Furthermore, circulating follistatin levels, adjusted for age, sex, and total body fat mass, were found to be elevated in patients with nonalcoholic fatty liver disease (NAFLD, Fig. 2b). This evidence concerns the gene FST and metabolic dysfunction-associated steatotic liver disease.